Overcoming the phage replication threshold: a mathematical model with implications for phage therapy

被引:147
作者
Kasman, LM
Kasman, A
Westwater, C
Dolan, J
Schmidt, MG
Norris, JS
机构
[1] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29403 USA
[2] Coll Charleston, Dept Math, Charleston, SC 29424 USA
关键词
D O I
10.1128/JVI.76.11.5557-5564.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Prior observations of phage-host systems in vitro have led to the conclusion that susceptible host cell populations must reach a critical density before phage replication can occur. Such a replication threshold density would have broad implications for the therapeutic use of phage. In this report, we demonstrate experimentally that no such replication threshold exists and explain the previous data used to support the existence of the threshold in terms of a classical model of the kinetics of colloidal particle interactions in solution. This result leads us to conclude that the frequently used measure of multiplicity of infection (MOI), computed as the ratio of the number of phage to the number of cells, is generally inappropriate for situations in which cell concentrations are less than 10(7)/ml. In its place, we propose an alternative measure, MOIactual, that takes into account the cell concentration and adsorption time. Properties of this function are elucidated that explain the demonstrated usefulness of MOI at high cell densities, as well as some unexpected consequences at low concentrations. In addition, the concept of MOIactual allows us to write simple formulas for computing practical quantities, such as the number of phage sufficient to infect 99.99% of host cells at arbitrary concentrations.
引用
收藏
页码:5557 / 5564
页数:8
相关论文
共 16 条
[1]   Toward a more accurate quantitation of the activity of recombinant retroviruses: Alternatives to titer and multiplicity of infection [J].
Andreadis, S ;
Lavery, T ;
Davis, HE ;
le Doux, JM ;
Yarmush, ML ;
Morgan, JR .
JOURNAL OF VIROLOGY, 2000, 74 (03) :1258-1266
[2]   ATTACHMENT OF MALE-SPECIFIC BACTERIOPHAGE F1 TO SENSITIVE STRAINS OF ESCHERICHIA COLI [J].
CARO, LG ;
SCHNOS, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1966, 56 (01) :126-&
[3]   Bacterial quorum sensing in pathogenic relationships [J].
de Kievit, TR ;
Iglewski, BH .
INFECTION AND IMMUNITY, 2000, 68 (09) :4839-4849
[4]   FILAMENTOUS COLIPHAGE M13 AS A CLONING VEHICLE - INSERTION OF A HINDII FRAGMENT OF LAC REGULATORY REGION IN M13 REPLICATIVE FORM INVITRO - (SINGLE-STRANDED-DNA PHAGE-BLUNT END LIGATION LACTOSE OPERON ALPHA-COMPLEMENTATION) [J].
MESSING, J ;
GRONENBORN, B ;
MULLERHILL, B ;
HOFSCHNEIDER, PH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (09) :3642-3646
[5]   RETROVIRUS INFECTION - EFFECT OF TIME AND TARGET-CELL NUMBER [J].
MORGAN, JR ;
LEDOUX, JM ;
SNOW, RG ;
TOMPKINS, RG ;
YARMUSH, ML .
JOURNAL OF VIROLOGY, 1995, 69 (11) :6994-7000
[6]   Prokaryotic gene therapy to combat multidrug resistant bacterial infection [J].
Norris, JS ;
Westwater, C ;
Schofield, D .
GENE THERAPY, 2000, 7 (09) :723-725
[7]   Understanding bacteriophage therapy as a density-dependent kinetic process [J].
Payne, RJH ;
Jansen, VAA .
JOURNAL OF THEORETICAL BIOLOGY, 2001, 208 (01) :37-48
[8]   Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals [J].
Payne, RJH ;
Jansen, VAA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (03) :225-230
[9]   FORMATION, INDUCTION, AND CURING OF BACTERIOPHAGE P1 LYSOGENS [J].
ROSNER, JL .
VIROLOGY, 1972, 48 (03) :679-&
[10]   SOME PHYSICAL-CHEMICAL + BIOLOGICAL PROPERTIES OF ROD-SHAPED COLIPHAGE M13 [J].
SALIVAR, WO ;
TZAGOLOFF, H ;
PRATT, D .
VIROLOGY, 1964, 24 (03) :359-+